This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Sunnybrook Health Sciences Centre. Active years: 2014-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toronto, CA (2014)
- Germantown, MD (US) (2017 - 2019)
Company Filing History:
Years Active: 2014-2019
Title: Ross La Motte-Mohs: Innovator in Cellular Therapy
Introduction
Ross La Motte-Mohs is a prominent inventor based in Germantown, MD (US). He has made significant contributions to the field of cellular therapy, particularly in the development of human progenitor T-cells. With a total of 3 patents to his name, his work has the potential to impact various medical applications.
Latest Patents
One of his latest patents focuses on transforming human progenitor T-cells into NK cells. This innovation describes human progenitor T cells that can successfully engraft a murine thymus and differentiate into mature human T and NK cells. The human progenitor T cells exhibit the phenotype CD34+CD7+CD1a−CD5− or CD34+CD7+CD1a−CD5+ and are derived from human hematopoietic stem cells, embryonic stem cells, and induced pluripotent stem cells through coculture with cells expressing a Notch receptor ligand (OP9-DL1 or OP9-DL4). These cells are valuable for various applications, including immune reconstitution, treatment of immunodeficiencies, and as carriers for genes used in gene therapy.
Another patent by La Motte-Mohs also describes the production of human CD34+CD7+CD5+CD1a− progenitor T cells. Similar to his previous work, this patent outlines the successful engraftment of these cells in a murine thymus and their differentiation into mature human T and NK cells. The applications of these cells are extensive, further emphasizing their importance in medical research and treatment.
Career Highlights
Ross La Motte-Mohs is currently affiliated with Sunnybrook Health Sciences Centre, where he continues to advance his research in cellular therapies. His work is characterized by a commitment to improving patient outcomes through innovative scientific approaches.
Collaborations
Throughout his career, La Motte-Mohs has collaborated with notable colleagues, including Juan Carlos Zuniga-Pflucker and Geneve Sheandra Awong. These collaborations have contributed to the advancement of his research and the development of groundbreaking therapies.
Conclusion
Ross La Motte-Mohs is a distinguished inventor whose work in cellular therapy is paving the way for new medical treatments. His innovative patents and collaborations highlight his dedication
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile